Nanotechnology & Medical Devices: Risk, Regulation and ‘Meta’ Registration
Full Text: 10-1260_1708-5284-10-3-191.pdf
A new approach to risk assessment for nanotechnology in healthcare includes the mapping of particles to risk profiles and the potential channels for the collection of relevant information. This relates assay type to processes probed and the recognition of the relevance of this to particle pathways. It is only by ensuring the sound regulation of this throughout the ‘life cycle’ of translational research and development, which we can ensure the true provenance of materials that we intend to use in the clinical environment.
Citation
S. Grange, K. Chettiar, M. Arestu, P. Pilarski, P. Smitham, M. Loizidou, G. Jell. "Nanotechnology & Medical Devices: Risk, Regulation and ‘Meta’ Registration". World Journal of Engineering, 10(3), pp 191-198, September 2013.| Keywords: | Nanotechnology, Orthopaedics, Intercalation Complex, Nano-kaolinite, Power Ultrasonic |
| Category: | In Journal |
| Web Links: | DOI |
| Journal |
BibTeX
@article{Grange+al:13,
author = {Simon Grange and Kris Chettiar and Mateen Arestu and Patrick M.
Pilarski and Peter Smitham and Marilena Loizidou and Gavin Jell},
title = {Nanotechnology & Medical Devices: Risk, Regulation and
‘Meta’ Registration},
Volume = "10",
Number = "3",
Pages = {191-198},
journal = {World Journal of Engineering},
year = 2013,
}Last Updated: November 10, 2020Submitted by Sabina P
